Back
Product details:
CAS
872511-34-7
Purity
95%
Infigratinib is an FGFR inhibitor used to treat locally advanced or metastatic cholangiocarcinoma in adults with a fibroblast growth factor receptor 2 (FGFR2) rearrangement.
Properties
Name
Infigratinib
Smiles
CCN1CCN(CC1)C=2C=CC(NC=3C=C(N=CN3)N(C)C(=O)NC=4C(Cl)=C(OC)C=C(OC)C4Cl)=CC2
Targets
Please log in to see this information
SDS
BGJ398 | NVP-BGJ398 | infigratinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
1 mg
$53
2 mg
$54
5 mg
$55
10 mg
$66
15 mg
$73
20 mg
$81
25 mg
$90
30 mg
$100
35 mg
$108
40 mg
$116
45 mg
$122
50 mg
$136
75 mg
$208
100 mg
$238
Quantity
1
Total amount
$ 55
BGJ398 | NVP-BGJ398 | infigratinib
No data available
The compound has purity validated by NMR and/or LCMS methods.
Target activity features
It should be emphasized that the product may be active against a larger number of targets than shown on the card. The information represented here refers to the targets with the largest value of pX or the targets with ΔpX less than 1.5 from the largest pX value.